India Pharmaceutical Forum 2018

A. Batch Failure Investigation Session 1 : Setting the Context- Mr Vivek Arora, McKinsey &amp; Co

Session 2, 3 &amp; 4 : Data Quality and Integrity 1, 2 &amp; 3- Mr Howard Sklamberg, Akin and Gump

Session 2 : How to Proceed - Essential Parameters- Dr Ademola Daramola, USFDA

Session 3 : Root Cause analysis- Dr Ademola Daramola, USFDA

Session 4 : Remediation, Resolution and Outcomes- Mr Andrei Spinei, EMA

Session 2 : Practical Steps to Good Documentation

Session 3 &amp; 4: How to Ensure Good Documentation Practice - Consequences of Poor Documentation- Mr Gerald Heddell/Mr Mark Birse, MHRA

Session 2: Reflections on Journey So Far- Mr Vikas Bhadoria, McKinsey &amp; Co

Session 2: Reflections on Journey So Far- Dr Jaidev Rajpal, McKinsey &amp; Co

Session 2: Reflections on Journey So Far- Mr Vivek Arora, McKinsey &amp; Co

Session 2: Reflections on Journey So Far- Process Validation Guideline

Session 2: Reflections on Journey So Far- Good Documentation Practice Guideline

Session 4: Building Integrated Capabilities for Quality Excellence- Mr Bart Janssens, Boston Consulting Group

Session 3: Driving Sustainable Cultural Transformation- Mr Andrei Apinei - EMA

Session 5: Building Quality Metrics- Mr Howard Sklamberg, Akin Gump

Session 4: Building Integrated Capabilities for Quality Excellence- Mr David Keeling, McKinsey &amp; Co